You are here

Clinical Trials: Central Nervous System Diseases

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Monday, January 13, 2020 - 12:00
Condition:   Intraventricular Hemorrhage
Intervention:   Other: Human breast milk
Sponsors:   The Hospital for Sick Children;   MOUNT SINAI HOSPITAL
Not yet recruiting
Posted: Tuesday, January 7, 2020 - 12:00
Condition:   Amyotrophic Lateral Sclerosis
Intervention:   Biological: RAPA-501 Autologous T cells
Sponsors:   Rapa Therapeutics LLC;   Massachusetts General Hospital;   Hackensack Meridian Health
Not yet recruiting
Posted: Tuesday, January 7, 2020 - 12:00
Condition:   Huntington Disease
Intervention:   Biological: Cellavita-HD
Sponsors:   Azidus Brasil;   Cellavita Pesquisa Científica Ltda
Not yet recruiting
Posted: Thursday, December 19, 2019 - 12:00
Condition:   Spinal Cord Injuries
Intervention:   Biological: Neuro-Cells
Sponsor:   Neuroplast
Not yet recruiting
Posted: Wednesday, December 18, 2019 - 12:00
Conditions:   Refractory Depression;   Anxiety Disorders;   Neurodegenerative Diseases
Intervention:   Other: Exosomes
Sponsor:   Neurological Associates of West Los Angeles
Posted: Wednesday, October 23, 2019 - 12:00
Conditions:   Spinal Cord Injuries;   Tendinopathy;   Rotator Cuff Tears;   Shoulder Pain
Interventions:   Device: Lipogems;   Drug: Dexamethasone
Sponsor:   Kessler Foundation
Posted: Friday, October 11, 2019 - 12:00
Conditions:   Stroke;   Hemiparesis
Intervention:   Device: IpsiHand Treatment
Sponsors:   Columbia University;   Neurolutions, Inc.
Not yet recruiting
Posted: Tuesday, October 1, 2019 - 12:00
Condition:   Phenylketonurias
Intervention:   Drug: RTX-134
Sponsor:   Rubius Therapeutics
Posted: Friday, September 20, 2019 - 12:00
Condition:   Cerebral Palsy
Interventions:   Biological: Low HLA group CBU infusion;   Biological: High HLA group CBU infusion;   Other: Standard therapy
Sponsors:   State-Financed Health Facility "Samara Regional Medical Center Dinasty";   INBIO, LLC
Posted: Friday, September 20, 2019 - 12:00
Condition:   Acute Ischemic Stroke
Intervention:   Biological: UMC119-06
Sponsor:   Meridigen Biotech Co., Ltd.
Not yet recruiting